Article

Challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy

Author(s):

Lynda Charters
Conferences|EURETINA

A case study details the care of a patient who had already lost vision in one eye from a similar issue.

Related Videos
Image credit: ©Ophthalmology Times
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Related Content
Ocugen announces positive 2-year safety and efficacy update of Phase 1/2 OCU400 for treatment of retinitis pigmentosa
January 15th 2025

Ocugen announces positive 2-year safety and efficacy update of Phase 1/2 OCU400 for treatment of retinitis pigmentosa

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

New research links retinal imaging and deep learning to improved schizophrenia detection
January 11th 2025

New research links retinal imaging and deep learning to improved schizophrenia detection

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

RESTORE study highlights persistent vision recovery in patients with LHON with MT-ND4 mutation
January 4th 2025

RESTORE study highlights persistent vision recovery in patients with LHON with MT-ND4 mutation

Microdrops show promise for safer retinopathy of prematurity screening in preterm infants
January 3rd 2025

Microdrops show promise for safer retinopathy of prematurity screening in preterm infants

© 2025 MJH Life Sciences

All rights reserved.